These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 26799212

  • 21. Relationship between anti-Müllerian hormone (AMH) and insulin levels during different tanner stages in daughters of women with polycystic ovary syndrome.
    Sir-Petermann T, Ladrón de Guevara A, Codner E, Preisler J, Crisosto N, Echiburú B, Maliqueo M, Sánchez F, Perez-Bravo F, Cassorla F.
    Reprod Sci; 2012 Apr; 19(4):383-90. PubMed ID: 22344736
    [Abstract] [Full Text] [Related]

  • 22. Iron stores and obesity are negatively associated with ovarian volume and anti-Müllerian hormone levels in women with polycystic ovary syndrome.
    Yang JH, Chou CH, Yang WS, Ho HN, Yang YS, Chen MJ.
    Taiwan J Obstet Gynecol; 2015 Dec; 54(6):686-92. PubMed ID: 26700986
    [Abstract] [Full Text] [Related]

  • 23. Interactions between androgens, FSH, anti-Müllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary.
    Dewailly D, Robin G, Peigne M, Decanter C, Pigny P, Catteau-Jonard S.
    Hum Reprod Update; 2016 Nov; 22(6):709-724. PubMed ID: 27566840
    [Abstract] [Full Text] [Related]

  • 24. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP, Bentzen JG, Pinborg A, Loft A, Forman JL, Thuesen LL, Cohen A, Hougaard DM, Nyboe Andersen A.
    Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
    [Abstract] [Full Text] [Related]

  • 25. Serum anti-mullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women.
    Wachs DS, Coffler MS, Malcom PJ, Chang RJ.
    J Clin Endocrinol Metab; 2007 May; 92(5):1871-4. PubMed ID: 17299061
    [Abstract] [Full Text] [Related]

  • 26. Serum anti-Müllerian hormone and ovarian morphology assessed by magnetic resonance imaging in response to acupuncture and exercise in women with polycystic ovary syndrome: secondary analyses of a randomized controlled trial.
    Leonhardt H, Hellström M, Gull B, Lind AK, Nilsson L, Janson PO, Stener-Victorin E.
    Acta Obstet Gynecol Scand; 2015 Mar; 94(3):279-87. PubMed ID: 25545309
    [Abstract] [Full Text] [Related]

  • 27. Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism.
    Dewailly D, Pigny P, Soudan B, Catteau-Jonard S, Decanter C, Poncelet E, Duhamel A.
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4399-405. PubMed ID: 20610596
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.
    Pigny P, Merlen E, Robert Y, Cortet-Rudelli C, Decanter C, Jonard S, Dewailly D.
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5957-62. PubMed ID: 14671196
    [Abstract] [Full Text] [Related]

  • 30. Anti-müllerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries.
    Stubbs SA, Hardy K, Da Silva-Buttkus P, Stark J, Webber LJ, Flanagan AM, Themmen AP, Visser JA, Groome NP, Franks S.
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5536-43. PubMed ID: 16030171
    [Abstract] [Full Text] [Related]

  • 31. Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology.
    Bayrak A, Terbell H, Urwitz-Lane R, Mor E, Stanczyk FZ, Paulson RJ.
    Fertil Steril; 2007 Apr; 87(4):870-5. PubMed ID: 17224152
    [Abstract] [Full Text] [Related]

  • 32. Loss of anti-Müllerian hormone (AMH) immunoactivity due to a homozygous AMH gene variant rs10417628 in a woman with classical polycystic ovary syndrome (PCOS).
    Hoyos LR, Visser JA, McLuskey A, Chazenbalk GD, Grogan TR, Dumesic DA.
    Hum Reprod; 2020 Oct 01; 35(10):2294-2302. PubMed ID: 32918081
    [Abstract] [Full Text] [Related]

  • 33. Effects of supervised aerobic training on the levels of anti-Mullerian hormone and adiposity measures in women with normo-ovulatory and polycystic ovary syndrome.
    Al-Eisa E, Gabr SA, Alghadir AH.
    J Pak Med Assoc; 2017 Apr 01; 67(4):499-507. PubMed ID: 28420905
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The effect of myo-inositol/di-chiro-inositol on markers of ovarian reserve in women with PCOS undergoing IVF/ICSI: A systematic review and meta-analysis.
    Bhide P, Pundir J, Gudi A, Shah A, Homburg R, Acharya G.
    Acta Obstet Gynecol Scand; 2019 Oct 01; 98(10):1235-1244. PubMed ID: 30993683
    [Abstract] [Full Text] [Related]

  • 36. Serum anti-Müllerian hormone and inhibin B concentrations are not useful predictors of ovarian response during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome.
    Lie Fong S, Schipper I, de Jong FH, Themmen AP, Visser JA, Laven JS.
    Fertil Steril; 2011 Aug 01; 96(2):459-63. PubMed ID: 21719005
    [Abstract] [Full Text] [Related]

  • 37. Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins.
    Cassar S, Teede HJ, Moran LJ, Joham AE, Harrison CL, Strauss BJ, Stepto NK.
    Clin Endocrinol (Oxf); 2014 Dec 01; 81(6):899-906. PubMed ID: 25040369
    [Abstract] [Full Text] [Related]

  • 38. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
    Parahuleva N, Pehlivanov B, Orbecova M, Uchikova E, Ivancheva H.
    Akush Ginekol (Sofiia); 2014 Dec 01; 53(5):22-7. PubMed ID: 25558667
    [Abstract] [Full Text] [Related]

  • 39. Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.
    Pierre A, Peigné M, Grynberg M, Arouche N, Taieb J, Hesters L, Gonzalès J, Picard JY, Dewailly D, Fanchin R, Catteau-Jonard S, di Clemente N.
    Hum Reprod; 2013 Mar 01; 28(3):762-9. PubMed ID: 23321213
    [Abstract] [Full Text] [Related]

  • 40. Ovarian morphology in polycystic ovary syndrome: estimates from 2D and 3D ultrasound and magnetic resonance imaging and their correlation to anti-Müllerian hormone.
    Nylander M, Frøssing S, Bjerre AH, Chabanova E, Clausen HV, Faber J, Skouby SO.
    Acta Radiol; 2017 Aug 01; 58(8):997-1004. PubMed ID: 28273731
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.